Explore

Trendline Trendline
Repligen CEO's Stock Sale Triggers Share Price Drop

Repligen CEO's Stock Sale Triggers Share Price Drop

Repligen CEO's Stock Sale Triggers Share Price Drop
Trendline Trendline
Analog Devices to Announce Q2 Fiscal Year 2026 Financial Results, Impacting Stakeholders

Analog Devices to Announce Q2 Fiscal Year 2026 Financial Results, Impacting Stakeholders

Analog Devices to Announce Q2 Fiscal Year 2026 Financial Results, Impacting Stakeholders
Trendline Trendline
Endeavour Mining Executes Share Buyback and Resets Voting Rights

Endeavour Mining Executes Share Buyback and Resets Voting Rights

Endeavour Mining Executes Share Buyback and Resets Voting Rights
Trendline Trendline
Nasdaq CEO Discusses Q1 Results and Changes in IPO Landscape

Nasdaq CEO Discusses Q1 Results and Changes in IPO Landscape

Nasdaq CEO Discusses Q1 Results and Changes in IPO Landscape
Trendline Trendline
L’Oréal Stock Surges Following Strong Q1 Results, Boosting Investor Confidence

L’Oréal Stock Surges Following Strong Q1 Results, Boosting Investor Confidence

L’Oréal Stock Surges Following Strong Q1 Results, Boosting Investor Confidence
Trendline Trendline
Sidus Space Completes $58.5 Million Offering to Fund Expansion

Sidus Space Completes $58.5 Million Offering to Fund Expansion

Sidus Space Completes $58.5 Million Offering to Fund Expansion
Trendline Trendline
Spruce Biosciences Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants

Spruce Biosciences Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants

Spruce Biosciences Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants
Trendline Trendline
Spruce Biosciences Initiates Public Offering of Common Stock and Pre-Funded Warrants

Spruce Biosciences Initiates Public Offering of Common Stock and Pre-Funded Warrants

Spruce Biosciences Initiates Public Offering of Common Stock and Pre-Funded Warrants
Trendline Trendline
Spruce Biosciences Launches Public Offering to Fund Neurological Therapies

Spruce Biosciences Launches Public Offering to Fund Neurological Therapies

Spruce Biosciences Launches Public Offering to Fund Neurological Therapies
Trendline Trendline
West Pharmaceutical Services Set to Announce Q1 Earnings Amid Positive Market Sentiment

West Pharmaceutical Services Set to Announce Q1 Earnings Amid Positive Market Sentiment

West Pharmaceutical Services Set to Announce Q1 Earnings Amid Positive Market Sentiment
Trendline Trendline
Scholastic Announces $114 Million Stock Repurchase Plan

Scholastic Announces $114 Million Stock Repurchase Plan

Scholastic Announces $114 Million Stock Repurchase Plan
Trendline Trendline
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call

Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call

Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call